Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection
Clinical trial NCT05330455 · TERMINATED
Trial details
- NCT number
- NCT05330455
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-14
- Primary completion
- 2025-05-19
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.